Brief: Acucort's Drug Isicort Approved For Treatment Of COVID-19
03/02/2021 21:57
Feb 3 (Reuters) - AcuCort AB ACUC.TE :
* ACUCORT'S DRUG ISICORT® IS APPROVED FOR TREATMENT OF
COVID-19
* SWEDISH MPA GRANTED DRUG ISICORT INDICATION - TREATMENT OF
COVID-19 IN ADULTS, ADOLESCENTS NEEDING SUPPLEMENTAL OXYGEN
TREATMENT
Source text for Eikon: ID:nWkr1cNWrj
Further company coverage: ACUC.TE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AcuCort AB
See all newsBrief: Acucort Plans To Apply For U.S. Market Approval For Zeqmelit In 2026
Brief: AcuCort Signs Its First Commercial Agreement For Zeqmelit
Brief: Acucort AB Acucort Receives Marketing Authorization For Drug Zeqmelit By Norwegian Medicines Agency
Brief: Acucort Receives Marketing Authorization For The Drug Zeqmelit By The Danish Medicines Agency
Brief: AcuCort Is Granted Sme Status By The European Medicines Agency, EMA